Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Proceedings of a Sickle Cell Disease Ontology workshop - Towards the first comprehensive ontology for Sickle Cell Disease.

Mulder N, Nembaware V, Adekile A, Anie KA, Inusa B, Brown B, Campbell A, Chinenere F, Chunda-Liyoka C, Derebail VK, Geard A, Ghedira K, Hamilton CM, Hanchard NA, Haendel M, Huggins W, Ibrahim M, Jupp S, Kamga KK, Knight-Madden J, Lopez-Sall P, Mbiyavanga M, Munube D, Nirenberg D, Nnodu O, Ofori-Acquah SF, Ohene-Frempong K, Opap KB, Panji S, Park M, Pule G, Royal C, Sangeda R, Tayo B, Treadwell M, Tshilolo L, Wonkam A.

Appl Transl Genom. 2016 Mar 15;9:23-9. doi: 10.1016/j.atg.2016.03.005. eCollection 2016 Jun.

PMID:
27354937
2.

Sickle-Cell Disease in Nigerian Children: Parental Knowledge and Laboratory Results.

Obaro SK, Daniel Y, Lawson JO, Hsu WW, Dada J, Essen U, Ibrahim K, Akindele A, Brooks K, Olanipekun G, Ajose T, Stewart CE, Inusa BP.

Public Health Genomics. 2016;19(2):102-7. doi: 10.1159/000444475. Epub 2016 Mar 19.

PMID:
26991896
3.

A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.

Heeney MM, Hoppe CC, Abboud MR, Inusa B, Kanter J, Ogutu B, Brown PB, Heath LE, Jakubowski JA, Zhou C, Zamoryakhin D, Agbenyega T, Colombatti R, Hassab HM, Nduba VN, Oyieko JN, Robitaille N, Segbefia CI, Rees DC; DOVE Investigators.

N Engl J Med. 2016 Feb 18;374(7):625-35. doi: 10.1056/NEJMoa1512021. Epub 2015 Dec 8.

PMID:
26644172
4.

Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trial.

Howard J, Inusa B, Liossi C, Jacob E, Murphy PB, Hart N, Gavlak J, Sahota S, Chorozoglou M, Nwosu C, Gwam M, Gupta A, Rees DC, Thein SL, Reading IC, Kirkham FJ, Cheng MY.

Trials. 2015 Aug 25;16:376. doi: 10.1186/s13063-015-0883-y.

5.

Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature.

Danaee A, Inusa B, Howard J, Robinson S.

Transfus Med Rev. 2015 Oct;29(4):220-30. doi: 10.1016/j.tmrv.2015.06.001. Epub 2015 Jun 19. Review.

PMID:
26209603
6.

Juvenile polymyositis with unremitting pain and progressive loss of motor and bulbar function on a background of sickle cell disease.

Bali S, D'Cruz D, Lazaro M, Inusa BP.

BMJ Case Rep. 2015 Mar 27;2015. pii: bcr2014207579. doi: 10.1136/bcr-2014-207579.

PMID:
25819817
7.

13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.

De Montalembert M, Abboud MR, Fiquet A, Inati A, Lebensburger JD, Kaddah N, Mokhtar G, Piga A, Halasa N, Inusa B, Rees DC, Heath PT, Telfer P, Driscoll C, Al Hajjar S, Tozzi A, Jiang Q, Emini EA, Gruber WC, Gurtman A, Scott DA.

Pediatr Blood Cancer. 2015 Aug;62(8):1427-36. doi: 10.1002/pbc.25502. Epub 2015 Mar 23.

PMID:
25810327
8.

Cerebral microhaemorrhages secondary to fat embolus syndrome in sickle cell disease.

Alobeidi F, Inusa BP, Singh RR, U-King-Im JM.

Postgrad Med J. 2015 Jan;91(1071):55-6. doi: 10.1136/postgradmedj-2014-132984. No abstract available.

PMID:
25583740
9.

Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.

Galadanci NA, Abdullahi SU, Tabari MA, Abubakar S, Belonwu R, Salihu A, Neville K, Kirkham F, Inusa B, Shyr Y, Phillips S, Kassim AA, Jordan LC, Aliyu MH, Covert BV, DeBaun MR.

Pediatr Blood Cancer. 2015 Mar;62(3):395-401. doi: 10.1002/pbc.25289. Epub 2014 Nov 14.

10.

Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.

Beverung LM, Strouse JJ, Hulbert ML, Neville K, Liem RI, Inusa B, Fuh B, King A, Meier ER, Casella J, DeBaun MR, Panepinto JA; SIT trial investigators.

Am J Hematol. 2015 Feb;90(2):139-43. doi: 10.1002/ajh.23877.

11.

Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia.

Inusa B, Casale M, Booth C, Lucas S.

BMJ Case Rep. 2014 Oct 21;2014. pii: bcr2014205464. doi: 10.1136/bcr-2014-205464.

PMID:
25336550
12.

Wheezing is common in children with sickle cell disease when compared with controls.

Galadanci NA, Liang WH, Galadanci AA, Aliyu MH, Jibir BW, Karaye IM, Inusa BP, Vermund SH, Strunk RC, DeBaun MR.

J Pediatr Hematol Oncol. 2015 Jan;37(1):16-9. doi: 10.1097/MPH.0000000000000239.

13.

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF.

N Engl J Med. 2014 Aug 21;371(8):699-710. doi: 10.1056/NEJMoa1401731.

14.

Factors predicting future ACS episodes in children with sickle cell anemia.

DeBaun MR, Rodeghier M, Cohen R, Kirkham FJ, Rosen CL, Roberts I, Cooper B, Stocks J, Wilkey O, Inusa B, Warner JO, Strunk RC.

Am J Hematol. 2014 Nov;89(11):E212-7. doi: 10.1002/ajh.23819. Epub 2014 Aug 27.

15.

Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.

King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR.

Am J Hematol. 2014 Oct;89(10):E188-92. doi: 10.1002/ajh.23805. Epub 2014 Aug 4.

16.

Obstructive sleep apnea and sickle cell anemia.

Rosen CL, Debaun MR, Strunk RC, Redline S, Seicean S, Craven DI, Gavlak JC, Wilkey O, Inusa B, Roberts I, Goodpaster RL, Malow B, Rodeghier M, Kirkham FJ.

Pediatrics. 2014 Aug;134(2):273-81. doi: 10.1542/peds.2013-4223. Epub 2014 Jul 14.

17.

Assessing the quality of life of children with sickle cell anaemia using self-, parent-proxy, and health care professional-proxy reports.

Constantinou C, Payne N, Inusa B.

Br J Health Psychol. 2015 May;20(2):290-304. doi: 10.1111/bjhp.12099. Epub 2014 Apr 23.

PMID:
24758574
18.

Dilemma in differentiating between acute osteomyelitis and bone infarction in children with sickle cell disease: the role of ultrasound.

Inusa BP, Oyewo A, Brokke F, Santhikumaran G, Jogeesvaran KH.

PLoS One. 2013 Jun 6;8(6):e65001. doi: 10.1371/journal.pone.0065001. Print 2013.

19.

Nocturnal oxygen desaturation and disordered sleep as a potential factor in executive dysfunction in sickle cell anemia.

Hollocks MJ, Kok TB, Kirkham FJ, Gavlak J, Inusa BP, DeBaun MR, de Haan M.

J Int Neuropsychol Soc. 2012 Jan;18(1):168-73. doi: 10.1017/S1355617711001469. Epub 2011 Nov 24.

20.

Hydroxycarbamide use in young children with sickle-cell anaemia.

Obaro SK, Inusa B, Telfer P.

Lancet. 2011 Nov 19;378(9805):1777. doi: 10.1016/S0140-6736(11)61770-4. No abstract available.

PMID:
22098850
Items per page

Supplemental Content

Write to the Help Desk